Purifying Untagged Proteins: Affinity and Non-Affinity Options

1. Why Choose an Untagged Strategy?

Tags simplify capture but can change expression, folding, localization, charge, oligomerization, activity, interactions, immunogenicity, or structural homogeneity. Tag removal introduces a protease, a cleavage reaction, and additional purification. Native-sequence protein may therefore be preferable for structural studies, mechanistic biochemistry, therapeutic or diagnostic development, and products where a scar is unacceptable.

The tradeoff is lower initial selectivity. Instead of one engineered recognition event, untagged purification often combines several moderate-selectivity operations. This can be efficient when the target is abundant or has distinctive native properties. It can be difficult for low-abundance targets that closely resemble host proteins. Evaluate total process yield and quality rather than assuming tag-free is inherently more authentic or affinity-tag capture inherently simpler.

2. Build a Target–Feed–Process Profile

Document molecular mass, oligomeric state, estimated and experimental charge behavior, hydrophobicity, cofactors, glycosylation, binding partners, localization, solubility, activity assay, pH and salt stability, temperature sensitivity, protease susceptibility, and concentration limits. Characterize the feed for target concentration, host proteins, nucleic acids, lipids, particulates, conductivity, viscosity, and known high-abundance contaminants.

Use experimental charge behavior rather than theoretical pI alone. Surface patches, modifications, cofactors, and buffer composition affect retention. Similarly, molecular mass is only an imperfect proxy for hydrodynamic size. Early characterization reduces blind screening.

3. Native Affinity Options

A target may bind an immobilized substrate analog, inhibitor, cofactor, receptor, antibody, lectin, metal complex, heparin-like ligand, or other natural partner. Native affinity can provide high selectivity without an engineered sequence. The ligand must be accessible, stable, safely immobilized, and compatible with reversible elution. Strong biological binding can make elution as difficult as capture.

Immobilization orientation and spacer length determine whether the binding site is available. Ligand density can increase capacity but may create multipoint binding or steric crowding. Nonspecific interactions from the matrix or ligand must be measured using blank-media and competition controls. A soluble ligand competitor can support selective elution, while pH or salt changes may be used when the target remains stable.

When no ready-made medium exists, custom resin development can explore ligand coupling and matrix selection. A custom affinity step should be evaluated for ligand leakage, supply, cleaning, and lifetime if the method will extend beyond small research batches.

4. Non-Affinity Capture Options

Creative BioMart provides ion exchange media, hydrophobic interaction media, and size exclusion media. Product choice should follow the target, feed, scale, and step objective.

5. Build Capture, Intermediate, and Polishing Steps Orthogonally

The capture step should process the feed volume, recover target, and remove broad contaminant classes. It need not deliver final purity. An ion exchanger often provides a practical untagged capture because it combines capacity and concentration, but a native-affinity or selective precipitation step may be stronger when a distinctive property exists.

The intermediate step should address the largest remaining impurity problem using a different mechanism. If capture was cation exchange, an anion-exchange flow-through step can remove nucleic acids or acidic host proteins under conditions where the target does not bind; hydrophobic interaction can exploit a separate surface property. Polishing then removes product-related species such as aggregate, fragment, oligomer, or charge variant.

6. Screen Mechanisms Efficiently

1. Define responses. Include recovery, purity, activity, target concentration, specific impurities, pool volume, pressure, and time.
2. Map stability. Exclude pH, salt, additive, and temperature regions that damage the target.
3. Run small binding screens. For ion exchange, vary pH and conductivity; for hydrophobic interaction, vary salt type/concentration and ligand hydrophobicity; for native affinity, vary ligand density and elution.
4. Separate ranking from optimization. Identify mechanisms with useful selectivity before optimizing gradients and load.
5. Confirm under flow. Batch results do not fully predict packed-bed transport, efficiency, or pressure.
6. Challenge feed variability. Repeat promising conditions with independent preparations.

Measure mass balance across every screen. A condition with high apparent purity may have discarded most target. Use activity or an integrity assay to distinguish intact target from co-migrating protein. For low-abundance proteins, sensitive target-specific analytics are indispensable.

7. Example Untagged Purification Routes

8. Scale-Up and Lifecycle Questions

Scale capture around dynamic capacity and residence time, not static batch binding. Confirm pressure–flow behavior in the real feed, because viscosity and particulates can dominate. Preserve gradient slope in column volumes where resolution depends on it, while accounting for system mixing and delay. Recheck recovery, impurity clearance, pool volume, and activity at scale.

Industrial workflows must include cleaning, storage, reuse, raw-material quality, lot consistency, and supply. Native affinity ligands may be less chemically stable than synthetic ion-exchange groups and can leach. Cycle studies should monitor functional capacity, recovery, pressure, impurity clearance, and product quality. For research workflows, reproducible buffer preparation and fraction criteria still matter even when reuse is limited.

Creative BioMart's protein purification services and method development support can evaluate tag-free routes when no single platform capture is obvious.

9. Common Untagged Purification Errors

• Selecting ion-exchange pH from theoretical pI without checking target stability or experimental retention.
• Using size exclusion as a high-volume crude capture step despite low volumetric loading and dilution.
• Adding steps for incremental purity without defining which impurity each removes.
• Optimizing a stained gel while ignoring activity, yield, aggregate, and target identity.
• Assuming native-affinity ligands bind every functional form equally; the step may bias isoforms.
• Skipping feed conditioning and then attributing high pressure or poor capacity to the resin.
• Choosing two steps with similar selectivity and calling the sequence orthogonal.
• Deferring cleaning and supply considerations until after a difficult custom method is established.

10. A Go/No-Go Decision for Tag-Free Purification

Before committing to an untagged route, compare it with at least one realistic tagged alternative on final-product outcomes. The tag-free process is favored when it preserves a required native sequence or function and achieves acceptable recovery, purity, activity, and reproducibility with a manageable number of steps. It may be the wrong choice when the target is extremely dilute, lacks a distinctive native property, or is unstable during the broader screens needed to find selectivity.

Build a simple process model. Estimate product mass entering each step, step yield, pool volume, cycle time, buffer demand, resin volume, number of batches, and analytical burden. Multiply step yields to expose compounding loss: three steps at individually acceptable recovery can still deliver a disappointing final yield. Include the cost of a tag-removal operation in the comparator rather than treating tagged capture as one step.

Use a checkpoint after the first capture study. Continue only if the step concentrates the target and removes a meaningful impurity class within its stability window. If it merely shifts contaminants, reconsider the mechanism, feed conditioning, or expression strategy. A disciplined no-go decision can save more material than extensive optimization of a separation with fundamentally weak selectivity.

Minimum dossier for a selected route

• Target and impurity mass balance across every operation
• Target-specific activity or integrity result
• Representative chromatograms and fraction analyses
• Defined load, wash, elution, and pool criteria
• Pressure, buffer, time, and scale assumptions
• Cleaning, storage, and reuse plan appropriate to the program

References

1. Carta G, Jungbauer A. Protein Chromatography: Process Development and Scale-Up. 2nd ed. Wiley-VCH; 2020.
2. Scopes RK. Protein Purification: Principles and Practice. 3rd ed. Springer; 1994.
3. Wheelwright SM. Designing downstream processes for large-scale protein purification. Bio/Technology. 1987;5:789–793.